Expression and clinical implications of RhoC in human glioma

Guang-hui YANG,Bin SHI,Yi-min FAN,Xiao-dong LIU,Wang MIAO
DOI: https://doi.org/10.3969/j.issn.1671-2560.2012.06.010
2012-01-01
Abstract:Objective To investigate RhoC expression in human glioma tissues and the correlation with pathological grading, and explore the implications for diagnosis, malignancy and prognosis assessment in patients with glioma. Methods The 62 astrocytoma samples of various pathological gradings and 11 samples of normal cerebral tissues were subjected to SABC immunohistochemistry assay and reverse transcription polymerase chain reaction (RT-PCR) for determination of RhoC protein and mRNA expression. Results In contrast to weak or absence of expression, RhoC protein tested positive in 62 glioma tissues, as suggested by immunohistochemistry assay. Astrocytoma of various grades exhibited difference in the proportion of cells with positive RhoC expression and the ratio of RhoC mRNA and GAPDH mRNA gray scale. No difference was revealed between grade Ⅰ and grade Ⅱ as well as between grade Ⅲ and grade Ⅳ (all P<0.05). Higher RhoC mRNA expression was found in grade Ⅲ and Ⅳ as compared with gradeⅠ and Ⅱ. Additionally, the proportion of RhoC positive cells was positively correlated with RhoC mRNA expression and pathological grading of glioma (r=0.814 and 0.863, respectively, both P<0.01). Conclusion RhoC expression is present in all 62 glioma samples, the extent of which is positively correlated with pathological grading, suggesting that RhoC may serve as a novel and efficient diagnostic marker for grade Ⅰ to Ⅳ astrocytoma and a complement to routine criteria for histopathological grading.
What problem does this paper attempt to address?